Single-use bioprocessing systems are a collection of disposable equipment and consumables used in the manufacture of biopharmaceuticals. These systems are intended to be used once and then discarded, reducing the requirement for cleaning, sterilisation, and validation that is associated with standard stainless-steel equipment.
Global Single-use Bioprocessing Systems Market was valued at US$ 9,875.6 million in 2022 and is anticipated to reach US$ 35,165.8 million by the end of 2030 expected to register a CAGR of 17.2% from 2023 to 2030.
Single-use bioprocessing devices have become increasingly popular due to their versatility, speed, and cost-effectiveness. Biopharmaceutical companies can quickly and easily adjust to changing production demands, reduce contamination risk, and lower capital and operational expenses. The market offers a range of components for single-use bioprocessing systems, including bags, filters, bioreactors, mixers, connections, tubing, and other accessories, which are used throughout the biopharmaceutical production process, including cell culture, filtration, purification, and formulation.
The market for single-use bioprocessing systems is being driven by several factors, including increasing demand for biopharmaceuticals, the need for cost-effective manufacturing solutions, and a growing desire for flexible and modular production systems. In the coming years, the market is expected to expand further as biopharmaceutical companies increasingly adopt single-use solutions to address the challenges of a rapidly changing industry.
Single-use Bioprocessing Systems Market amid COVID-19 Pandemic:
The COVID-19 pandemic has had a significant impact on the healthcare industry, particularly the biopharmaceutical production sector. With the unprecedented demand for vaccinations, diagnostics, and therapies, biopharmaceutical makers have faced many challenges. However, many companies have increased their production capacity to meet the rising demand for COVID-19 vaccines and medicines, with single-use bioprocessing solutions playing a critical role in their success.
Single-use bioprocessing devices provide several advantages in the context of the COVID-19 pandemic. They offer quick and flexible manufacturing processes that can easily adapt to changing production demands, while also reducing the need for cleaning and sterilization, which can improve efficiency and reduce contamination. Moreover, the need for vaccines and treatments has increased the market for single-use systems, and many biopharmaceutical businesses have invested in these systems to expand their manufacturing capacity.
Despite the opportunities that the pandemic has created for industry expansion and innovation, it has also posed several obstacles for the market of single-use bioprocessing devices. The disruption of global supply chains has resulted in shortages of raw materials and components, affecting the development of single-use systems. Additionally, the strong demand for single-use systems has led to price increases and supply chain concerns.
Overall, the COVID-19 pandemic has had a significant impact on the market for single-use bioprocessing equipment, with both challenges and opportunities arising as a result..
Factors responsible for the boost in the Single-use Bioprocessing Systems Market:
The market for single-use bioprocessing systems is on the rise due to several contributing factors. Firstly, there is a growing demand for biopharmaceuticals globally, driven by the increasing prevalence of chronic illnesses, an aging population, and the development of new biologics. Single-use bioprocessing systems offer a flexible and cost-effective solution for biopharmaceutical companies to meet this demand.
In addition, single-use systems have several advantages over traditional stainless-steel equipment, including a reduced risk of contamination, increased flexibility, and less time required for cleaning and validation. These benefits have led to an increased demand for single-use systems in biopharmaceutical production.
Single-use bioprocessing systems are also more affordable than traditional stainless-steel equipment, particularly for small to medium-scale biopharmaceutical production. They do not require cleaning, sterilization, or validation, which minimizes capital and running costs.
Modular manufacturing is gaining popularity in the biopharmaceutical sector, allowing producers to quickly and easily adjust to changing production demands. Single-use bioprocessing systems are a vital component of modular production systems due to their flexibility and ease of use.
Outsourcing of manufacturing operations to contract research and manufacturing groups (CROs and CMOs) is also becoming increasingly popular. CROs and CMOs choose single-use bioprocessing systems due to their cost-effectiveness, scalability, and flexibility.
Finally, technological advancements have led to the development of high-performance single-use systems with greater efficiency, scalability, and reliability. Overall, the rising demand for biopharmaceuticals, the benefits of single-use systems, cost-effectiveness, a growing preference for modular production and outsourcing, and technological improvements are all contributing to the growth of the single-use bioprocessing systems market.
Emerging Markets for Single-use Bioprocessing Systems Market:
The Asia-Pacific single-use bioprocessing systems market is growing due to the increasing demand for biopharmaceuticals. This demand is driven by the region’s ageing population and high burden of chronic illnesses, leading to a need for new biologics. To meet this demand, producers are turning to cost-effective and flexible single-use bioprocessing systems.
Investments in biopharmaceutical research and development are also contributing to the growth of this market. Countries like China, India, and South Korea have made significant investments in this field, resulting in a rise in the biopharmaceutical sector and an increased demand for single-use bioprocessing equipment.
The expanding biomanufacturing industry in the region is another factor boosting demand for single-use bioprocessing equipment. Many biomanufacturing facilities are using modular manufacturing systems, which require flexible and cost-effective production equipment like single-use systems.
Overall, the Asia-Pacific area is becoming a lucrative market for single-use bioprocessing equipment due to the increased demand for biopharmaceuticals, investments in biopharmaceutical R&D, and a growing biomanufacturing industry.
Competitive Insights:
The market for single-use bioprocessing systems is highly competitive, with several leading companies dominating it. These companies are investing heavily in research and development to create innovative and cost-effective single-use bioprocessing technologies.
Strategic collaborations and alliances are formed by two or more companies to achieve a shared goal in the single-use bioprocessing systems industry. Manufacturers, suppliers, and other stakeholders can collaborate to develop new products, enhance existing ones, or expand their market reach. For instance, in 2019, Thermo Fisher Scientific and Samsung Biologics established a strategic agreement to develop and deliver biopharmaceutical production solutions, including single-use bioprocessing systems.
Product launches and innovations involve introducing new or improved items into the market. Companies in the single-use bioprocessing systems market are significantly investing in research and development to create groundbreaking solutions that are more cost-effective, efficient, and user-friendly. Merck KGaA is an example of such a company.
Expansion refers to the process of growing a company’s presence in existing markets or entering new ones. Companies in the single-use bioprocessing systems market are expanding their operations to meet the growing demand for single-use systems worldwide. Sartorius AG, for example, will establish a new production plant in Yauco, Puerto Rico in 2021 to increase its manufacturing capacity for single-use bioprocessing equipment.
Acquisitions and mergers involve one company buying or merging with another. These transactions can help organizations gain access to new technology, products, and markets, as well as strengthen their competitive position in the single-use bioprocessing systems market. For instance, Repligen Corporation acquired Polymem S.A., a French manufacturer of hollow fiber membrane products used in the bioprocessing sector, in 2021.
These companies are using various tactics to maintain their market position and gain a competitive advantage. Some of these tactics include mergers and acquisitions, collaborations and partnerships, product launches and innovations, and regional expansions.
